๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cisplatin, bleomycin, and methotrexate (PBM) chemotherapy in locally advanced and metastatic head and neck cancer

โœ Scribed by Dr. B. Uziely; T. Peretz; A. Sulkes; E. Feigin; R. Isacson; S. Biran


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
418 KB
Volume
42
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Multidrug chemotherapy using bleomycin,
โœ Dr. J. Zidan; A. Kuten; Y. Cohen; E. Robinson ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 266 KB ๐Ÿ‘ 2 views

Thirty-one patients with Stage III-IV head and neck squamous cell cancer were treated by three courses of combination chemotherapy using bleomycin, methotrexate, and cisplatin followed by a radical course of radiation and in two cases by surgery. Of 29 evaluable patients, 4 (14%) achieved complete r

Concomitant weekly cisplatin and altered
โœ Heather E. Newlin; Robert J. Amdur; Charles E. Riggs; Christopher G. Morris; Jes ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 144 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND: Both concomitant chemotherapy and altered fractionation radiotherapy (RT) have been shown to improve outcomes for patients with locoregionally advanced head and neck squamous cell carcinomas. However, both strategies also increase acute toxicity, and it is questionable w

Chemotherapy of head and neck cancer: Co
โœ Wittes, Robert E. ;Spiro, Ronald H. ;Shah, Jatin ;Gerold, Frank P. ;Koven, Berna ๐Ÿ“‚ Article ๐Ÿ“… 1977 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 470 KB

## Abstract A combination of cyclophosphamide, adriamycin, methotrexate, and bleomycin (CAMB) was explored in patients with advanced, nonresectable epidermoid carcinoma from primary sites in the head and neck, recurrent or persistent after radiation or surgery. Objective regression (greater than 50

Combination chemotherapy with methotrexa
โœ M. Clavel; F. Cognetti; P. Dodion; J. Wildiers; R. Rosso; A. Rossi; B. Gignoux; ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 449 KB ๐Ÿ‘ 2 views

## For the EORTC Head and Neck Cooperative Group A total of 185 eligible patients with advanced inoperable squamous cell carcinoma of the head and neck were randomized into two groups; the cisplatin, methotrexate, bleomycin, and vincristine (CABO) group received cisplatin (50 mg/m2; day 4), methot